SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout!
LGND 205.55-1.3%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SnowShredder who wrote (17755)3/20/1998 7:34:00 AM
From: Mudcat  Read Replies (4) of 32384
 
Just read an article in the paper this morning concerning a drug that slows breast cancer. The drug is called XELODA and is administered in pill form. Hoffman-LaRouche is the drug maker. Article states it works in slowing tumor growth in 20% of patients. Article also states that there are not many options for breast cancer treatment after Taxol. This appears to be good news for Lgnd but few on the street will be able to figure it out. Does anyone know why Lgnd doesn't get their good news like the breast cancer rat results to be covered as a news item and not a company press release?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext